Tudor Investment Corp ET AL Decreases Stake in Chemed Corporation $CHE

Tudor Investment Corp ET AL decreased its holdings in shares of Chemed Corporation (NYSE:CHE) by 81.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,106 shares of the company’s stock after selling 4,952 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Chemed were worth $495,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Smartleaf Asset Management LLC increased its holdings in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the last quarter. First Horizon Corp acquired a new position in Chemed during the third quarter worth $31,000. Geneos Wealth Management Inc. grew its holdings in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after buying an additional 76 shares in the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new stake in Chemed in the 3rd quarter valued at $45,000. Finally, HM Payson & Co. increased its stake in shares of Chemed by 35.5% in the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after acquiring an additional 27 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the transaction, the chief executive officer directly owned 93,719 shares in the company, valued at $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 3.29% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on CHE shares. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Finally, Oppenheimer reduced their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $498.00.

Chemed Trading Up 0.1%

Shares of NYSE:CHE opened at $378.25 on Thursday. The company has a market capitalization of $5.21 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 1.50 and a beta of 0.49. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $623.60. The business has a 50-day moving average price of $423.62 and a 200 day moving average price of $433.75.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). The company had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the business earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts predict that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were given a $0.60 dividend. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s payout ratio is presently 13.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.